Last Updated : March 6, 2008
Details
FilesGeneric Name:
Daptomycin
Project Status:
Complete
Therapeutic Area:
Skin and skin structure infections & bacteremia
Manufacturer:
Cubist Pharmaceuticals Inc.
Brand Name:
Cubicin
Project Line:
Reimbursement Review
Project Number:
SR0127-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Skin and skin structure infections & bacteremia
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 6, 2008